David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Newmark Group
NMRK
$2.9B
| $358K | ﹤0.01% |
42,879
-36,308
| -46% | -$344K |
|
3102
Resources Connection
RGP
$147M
| $358K | ﹤0.01% |
+21,652
| New | +$362K |
|
|
BITA
3103
DELISTED
Bitauto Holdings Limited
BITA
| $358K | ﹤0.01% |
22,473
+13,988
| +165% | +$257K |
|
3104
Tennant Co
TNC
$1.19B
| $357K | ﹤0.01% |
+5,743
| New | +$344K |
|
3105
CALL
Best Buy
BBY
$18B
| $355K | ﹤0.01% |
5,000
| – | – |
|
3106
PUT
Cognizant
CTSH
$28.4B
| $355K | ﹤0.01% |
4,900
-20,900
| -81% | -$1.46M |
|
3107
CALL
Iron Mountain
IRM
$36B
| $355K | ﹤0.01% |
+10,000
| New | +$353K |
|
3108
PUT
Medtronic
MDT
$117B
| $355K | ﹤0.01% |
+3,900
| New | +$349K |
|
3109
PUT
National Beverage
FIZZ
$3.12B
| $352K | ﹤0.01% |
12,200
+4,000
| +49% | +$142K |
|
3110
PUT
Rambus
RMBS
$9.75B
| $351K | ﹤0.01% |
33,600
| – | – |
|
|
BERY
3111
CALL
DELISTED
Berry Global Group, Inc.
BERY
| $350K | ﹤0.01% |
7,079
| – | – |
|
3112
BJ's Restaurants
BJRI
$1.39B
| $349K | ﹤0.01% |
7,392
-92,865
| -93% | -$4.66M |
|
3113
Ulta Beauty
ULTA
$23.1B
| $349K | ﹤0.01% |
1,000
-100
| -9% | -$30.2K |
|
3114
Kennametal
KMT
$2.23B
| $348K | ﹤0.01% |
+9,464
| New | +$346K |
|
3115
Enphase Energy
ENPH
$4.94B
| $346K | ﹤0.01% |
37,503
-122,561
| -77% | -$932K |
|
3116
SAP
SAP
$250B
| $346K | ﹤0.01% |
3,000
-216,788
| -99% | -$23.1M |
|
|
KDNY
3117
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $346K | ﹤0.01% |
17,407
+9,330
| +116% | +$163K |
|
3118
PUT
Ryanair
RYAAY
$29.7B
| $345K | ﹤0.01% |
+11,500
| New | +$333K |
|
|
AAWW
3119
CALL
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $344K | ﹤0.01% |
6,800
-2,300
| -25% | -$116K |
|
3120
Stagwell
STGW
$2.13B
| $343K | ﹤0.01% |
152,352
-110,125
| -42% | -$302K |
|
3121
Unitil
UTL
$983M
| $343K | ﹤0.01% |
6,338
-2,364
| -27% | -$123K |
|
|
OPI
3122
DELISTED
Office Properties Income Trust
OPI
| $342K | ﹤0.01% |
+12,382
| New | +$375K |
|
3123
Metropolitan Bank Holding Corp
MCB
$1.13B
| $341K | ﹤0.01% |
9,792
+594
| +6% | +$21.2K |
|
3124
Neurogene
NGNE
$817M
| $341K | ﹤0.01% |
6,318
-8,914
| -59% | -$450K |
|
3125
NMI Holdings
NMIH
$3.41B
| $340K | ﹤0.01% |
13,132
-22,734
| -63% | -$518K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.